Published February 4, 2024 | Version v1
Report Open

Preliminary Report: Complete Remission of Obsessive Thoughts in H63D Syndrome Type-3 (Oshtoran Syndrome) Patients Following Corticosteroid Therapy

  • 1. LCG Research
  • 2. International H63D Research Consortium

Description

This preliminary report outlines clinical observations of two patients diagnosed with H63D Syndrome Type-3, also known as Oshtoran Syndrome. A 42-year-old woman from Malaysia and a 38-year-old man from Iran presented with complete remission of their obsessive thoughts caused by Oshtoran Syndrome. Alongside the administration of the Amitradicain formula, both patients received a high-dose corticosteroid treatment, resulting in the disappearance of all neuropsychiatric symptoms.

Files

Corticosteroids vs OCD V2.pdf

Files (241.7 kB)

Name Size Download all
md5:ab8d8f42a324a1862fbeac0c3b78b910
241.7 kB Preview Download